To further evaluate the prognostic value of p53 expression, we conducted a time-dependent ROC analysis for the censored data, which indicated that combination of clinical risk score (TNM stage, histological type and tumor diameter) and p53 contributed much more than clinical parameters alone in both training and testing cohorts (Fig. 3). Here, TP53 is linked to neoplasm.